These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16539892)

  • 1. Beyond the DSM: defining endophenotypes for genetic studies of substance abuse.
    Frederick JA; Iacono WG
    Curr Psychiatry Rep; 2006 Apr; 8(2):144-50. PubMed ID: 16539892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude.
    Iacono WG; Malone SM; McGue M
    Int J Psychophysiol; 2003 May; 48(2):147-78. PubMed ID: 12763572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished error-related brain activity as a promising endophenotype for substance-use disorders: evidence from high-risk offspring.
    Euser AS; Evans BE; Greaves-Lord K; Huizink AC; Franken IH
    Addict Biol; 2013 Nov; 18(6):970-84. PubMed ID: 23145495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Event-related potentials in substance use disorders: a narrative review based on articles from 1984 to 2012.
    Campanella S; Pogarell O; Boutros N
    Clin EEG Neurosci; 2014 Apr; 45(2):67-76. PubMed ID: 24104954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain electrophysiological endophenotypes for externalizing psychopathology: a multivariate approach.
    Gilmore CS; Malone SM; Iacono WG
    Behav Genet; 2010 Mar; 40(2):186-200. PubMed ID: 20155392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a review.
    Singh SM; Basu D
    Addict Biol; 2009 Jul; 14(3):298-309. PubMed ID: 18811679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of addiction-a translational perspective.
    Agrawal A; Verweij KJ; Gillespie NA; Heath AC; Lessov-Schlaggar CN; Martin NG; Nelson EC; Slutske WS; Whitfield JB; Lynskey MT
    Transl Psychiatry; 2012 Jul; 2(7):e140. PubMed ID: 22806211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal stability and predictive utility of the visual P3 response in adults with externalizing psychopathology.
    Yoon HH; Malone SM; Iacono WG
    Psychophysiology; 2015 Dec; 52(12):1632-45. PubMed ID: 26402396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys.
    Iacono WG; Carlson SR; Malone SM; McGue M
    Arch Gen Psychiatry; 2002 Aug; 59(8):750-7. PubMed ID: 12150652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying a multivariate endophenotype for substance use disorders using psychophysiological measures.
    Iacono WG; Carlson SR; Malone SM
    Int J Psychophysiol; 2000 Oct; 38(1):81-96. PubMed ID: 11027796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescents and substance-related disorders: research agenda to guide decisions on Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).
    Crowley TJ
    Addiction; 2006 Sep; 101 Suppl 1():115-24. PubMed ID: 16930168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P3 in young boys as a predictor of adolescent substance use.
    Berman SM; Whipple SC; Fitch RJ; Noble EP
    Alcohol; 1993; 10(1):69-76. PubMed ID: 8447968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minnesota Twin Family Study.
    Iacono WG; McGue M
    Twin Res; 2002 Oct; 5(5):482-7. PubMed ID: 12537881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the brain P300 response to identify novel phenotypes reflecting genetic vulnerability for adolescent substance misuse.
    Yoon HH; Iacono WG; Malone SM; McGue M
    Addict Behav; 2006 Jun; 31(6):1067-87. PubMed ID: 16644137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.
    Nunes EV; Rounsaville BJ
    Addiction; 2006 Sep; 101 Suppl 1():89-96. PubMed ID: 16930164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.
    Uhl GR; Drgon T; Johnson C; Li CY; Contoreggi C; Hess J; Naiman D; Liu QR
    Ann N Y Acad Sci; 2008 Oct; 1141():318-81. PubMed ID: 18991966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truth (validity) and use despite consequences: the DSM-5 substance use disorder unidimensional syndrome.
    Hasin D
    Addiction; 2014 Nov; 109(11):1781-2. PubMed ID: 25297956
    [No Abstract]   [Full Text] [Related]  

  • 19. EEG correlates of visual short-term memory as neuro-cognitive endophenotypes of ADHD.
    Wiegand I; Hennig-Fast K; Kilian B; Müller HJ; Töllner T; Möller HJ; Engel RR; Finke K
    Neuropsychologia; 2016 May; 85():91-9. PubMed ID: 26972967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSM-5 changes on the horizon: substance use disorders.
    Fitzgerald B; Morgan BD
    Issues Ment Health Nurs; 2012 Sep; 33(9):605-12. PubMed ID: 22957954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.